Investors are worrying about a lot more than just the omicron variant, if recent market moves are anything to go by.
While the newly discovered virus strain has been one of the main catalysts for the recent slump in U.S. stocks, action under the surface points to concerns about the Federal Reserve, inflation, valuations, year-end volatility and perhaps even some some profit-taking after a solid year of gains.
